Pharmacology News and Research

Latest Pharmacology News and Research

McGill University experts to present at World Cancer Congress

The following list includes some of the McGill University experts who will be attending or presenting at the World Cancer Congress (WCC), the largest gathering of international leaders in the field of cancer, taking place in Montreal from August 27 to 30, 2012.

24 Aug 2012

Preemptive cognitive training can help the brain function normally later in life

Preemptive cognitive training—an early intervention to address neuropsychiatric deficiencies—can help the brain function normally later in life, a team of researchers has found through a series of experiments on laboratory rats.

23 Aug 2012

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

A novel treatment in development at the University of Nevada School of Medicine for the most common form of muscular dystrophy is advancing towards human trials with a $308,000 boost from the Muscular Dystrophy Association.

23 Aug 2012

MitoTarget Project and neurodegenerative diseases: an interview with Rebecca Pruss, Ph.D., CSO of Trophos

The MitoTarget Project was a project funded by the European Commission, under their FP7 programme. It was funding for a call published in 2007.

21 Aug 2012

Researchers discover why people with sickle cell disease get milder cases of malaria

Researchers at Duke University Medical Center may finally have discovered why people with sickle cell disease get milder cases of malaria than individuals who have normal red blood cells.

16 Aug 2012

No aping around after anesthetic combination

A combination of medetomidine and ketamine administered intramuscularly to chimpanzees, orangutans, and gorillas results in reliable immobilization for both the animals and personnel handling them, report researchers.

15 Aug 2012

TAIN project aims to optimise treatment for babies with adrenal insufficiency

Groundbreaking research into rare neonatal diseases, conducted by the University of Sheffield, is set to improve the treatment of babies who lack the stress hormone cortisol.

15 Aug 2012

Medicine brand choices: an interview with Dr Lynn Weekes

In Australia, people will only be offered a choice when the brands are bioequivalent, meaning they contain the same active ingredient (i.e. the chemical in the medicine that makes it work) and have been proven to work the same in the body.

15 Aug 2012

Chronic nerve pain: researchers identify which sensory nerve cells are responsible

New research, led by academics at the University of Bristol and published in the journal Pain, has identified the subtypes of sensory nerve cells that are likely to contribute to long-term nerve pain from partial nerve injury. It is hoped this will aid in development of more effective pain killers.

13 Aug 2012

Scientists discover why major depression or chronic stress can cause loss of brain mass

Major depression or chronic stress can cause the loss of brain volume, a condition that contributes to both emotional and cognitive impairment. Now a team of researchers led by Yale scientists has discovered one reason why this occurs - a single genetic switch that triggers loss of brain connections in humans and depression in animal models.

13 Aug 2012

Scientists discover how pten gene causes brain changes that lead to autism-like behavior

Scientists affiliated with the UC Davis MIND Institute have discovered how a defective gene causes brain changes that lead to the atypical social behavior characteristic of autism. The research offers a potential target for drugs to treat the condition.

13 Aug 2012

Clinical trials to test safety of 3K3A-APC in patients with ischemic stroke

Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.

9 Aug 2012

PAREXEL board approves stock repurchase program

PAREXEL International Corporation announced today that its Board of Directors has approved a stock repurchase program authorizing the repurchase of up to $200 million of the Company's common stock, subject to the consent of the Company's lenders.

From Parexel 9 Aug 2012

Drug research “innovation crisis” is a myth

The widely touted “innovation crisis” in pharmaceutical research is a myth, argue experts in an article published on bmj.com today.

8 Aug 2012

Studies identify genetic mutations that play important roles in startle disease

Two studies published in the Journal of Biological Chemistry identify genetic mutations that play important roles in the condition commonly referred to as startle disease. Startle disease is characterized by an exaggerated response to noise and touch, which can interfere with breathing, cause catastrophic falls and even result in death.

8 Aug 2012

CPRIT awards $48.2 million in new grants to investigators at UT Southwestern Medical Center

The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded $48.2 million in new grants to investigators at UT Southwestern Medical Center to support cancer-related projects and to recruit pre-eminent cancer researchers.

6 Aug 2012

Medicines with the same active ingredient and size of dose will work the same in the body

In the wake of reports that a number of medicines will increase in price this week, NPS MedicineWise is reminding Australians that while the cost of a medicine may differ from brand to brand, if the active ingredient and size of the dose are the same then the medicine will work the same in their body.

6 Aug 2012

Alcohol decreases turnover of bone in post-menopausal women

Women after menopause tend to develop weaker bones from what is known as osteoporosis, which may lead to fractures (especially hip fractures) from falling. The weakness of the bones results from an imbalance between the normal resorption (a type of dissolving of old bone) and the laying down of new bone, an ongoing process for both men and women referred to as "bone turnover."

3 Aug 2012

Chk1 gene alone is sufficient to kill cancer cells

Researchers at Case Western Reserve University School of Medicine have discovered a mutant form of the gene, Chk1, that when expressed in cancer cells, permanently stopped their proliferation and caused cell death without the addition of any chemotherapeutic drugs.

1 Aug 2012

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

GenSpera, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared for initiation a Phase II human clinical trial of its lead compound, G-202, in the treatment of prostate cancer patients who have failed prior hormonal therapy.

31 Jul 2012

Pharmacology News and Research

Latest Pharmacology News and Research

McGill University experts to present at World Cancer Congress

Preemptive cognitive training can help the brain function normally later in life

Laminin-111 protein therapy could treat Duchenne muscular dystrophy

MitoTarget Project and neurodegenerative diseases: an interview with Rebecca Pruss, Ph.D., CSO of Trophos

Researchers discover why people with sickle cell disease get milder cases of malaria

No aping around after anesthetic combination

TAIN project aims to optimise treatment for babies with adrenal insufficiency

Medicine brand choices: an interview with Dr Lynn Weekes

Chronic nerve pain: researchers identify which sensory nerve cells are responsible

Scientists discover why major depression or chronic stress can cause loss of brain mass

Scientists discover how pten gene causes brain changes that lead to autism-like behavior

Clinical trials to test safety of 3K3A-APC in patients with ischemic stroke

PAREXEL board approves stock repurchase program

Drug research “innovation crisis” is a myth

Studies identify genetic mutations that play important roles in startle disease

CPRIT awards $48.2 million in new grants to investigators at UT Southwestern Medical Center

Medicines with the same active ingredient and size of dose will work the same in the body

Alcohol decreases turnover of bone in post-menopausal women

Chk1 gene alone is sufficient to kill cancer cells

GenSpera receives FDA clearance to commence G-202 Phase II trial in prostate cancer

Pittcon Highlights: Pharmaceutical & Biologic eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Pharmacology News and Research

Latest Pharmacology News and Research

Pittcon Highlights: Pharmaceutical & Biologic eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in